AU Patent

AU2014202221B2 — Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof

Assigned to Atnx Spv LLC United States · Expires 2016-06-23 · 10y expired

What this patent protects

The invention relates to compositions comprising 2-(5-(4-(2- morpholinoethoxy)phenyl)pyridin 2-yl)-N-benzylacetamide and its mesylate and dihydrochloride salts. More specifically, the invention provides an efficient process for the synthesis of 2-)5-<4-)2 morpholinoethoxy)phen…

USPTO Abstract

The invention relates to compositions comprising 2-(5-(4-(2- morpholinoethoxy)phenyl)pyridin 2-yl)-N-benzylacetamide and its mesylate and dihydrochloride salts. More specifically, the invention provides an efficient process for the synthesis of 2-)5-<4-)2 morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide and its mesylate and dihydrochloride salts and methods for modulating one or more components of a kinase cascade using the compositions of the invention.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014202221B2
Jurisdiction
AU
Classification
—
Expires
2016-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Atnx Spv LLC United States
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.